Category:Kevin Fitzgerald of Brookline MA (US)

Kevin Fitzgerald of Brookline MA (US)

Executive Summary

Kevin Fitzgerald of Brookline MA (US) is an inventor who has filed 6 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (6 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (5 patents), of the backbone (5 patents), and they have worked with companies such as Alnylam Pharmaceuticals, Inc. (6 patents). Their most frequent collaborators include (3 collaborations), (3 collaborations), (3 collaborations).

Patent Filing Activity

File:Kevin Fitzgerald of Brookline MA (US) Monthly Patent Applications.png

Technology Areas

File:Kevin Fitzgerald of Brookline MA (US) Top Technology Areas.png

List of Technology Areas

• C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 6 patents
• C12N2310/14 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
• C12N2310/315 (of the backbone): 5 patents
• A61K31/713 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 4 patents
• C12N2310/351 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
• C12N2310/321 (2'-O-R Modification): 3 patents
• C12N2310/3515 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
• C12N15/1137 ({against enzymes (viral enzymes): 2 patents
• C12N2310/322 (2'-R Modification): 2 patents
• C12N2310/343 (Spatial arrangement of the modifications): 2 patents
• C12N2310/344 (Spatial arrangement of the modifications): 2 patents
• C12N2310/3521 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
• A61K47/549 ({Sugars, nucleosides, nucleotides or nucleic acids}): 2 patents
• C12N2310/346 (Spatial arrangement of the modifications): 2 patents
• A61K47/60 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• A61K48/00 (Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy): 1 patents
• C12N2310/3533 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/50 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/533 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2320/30 (Special therapeutic applications): 1 patents
• C12Y203/01037 (ENZYMES): 1 patents
• A61K47/554 ({the modifying agent being a steroid plant sterol, glycyrrhetic acid, enoxolone or bile acid}): 1 patents
• C12N2310/318 (where the PO2 is completely replaced, e.g. MMI or formacetal): 1 patents
• A61K45/06 (Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca): 1 patents
• A61K31/00 (Medicinal preparations containing organic active ingredients): 1 patents
• A61K45/00 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C12Y101/03015 (ENZYMES): 1 patents
• A61K31/7105 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 1 patents
• C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/3125 (of the backbone): 1 patents
• C12N2310/313 (of the backbone): 1 patents
• C12N2310/3231 (modified ring structure): 1 patents
• C12N2310/3523 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12N2310/3525 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
• C12Y101/01027 (ENZYMES): 1 patents
• A61P1/16 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P1/18 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/04 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/06 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P3/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/10 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P9/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P13/12 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P15/08 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
• A61P43/00 (Drugs for specific purposes, not provided for in groups): 1 patents
• C12N2310/335 (of the base): 1 patents

Companies

File:Kevin Fitzgerald of Brookline MA (US) Top Companies.png

List of Companies

• Alnylam Pharmaceuticals, Inc.: 6 patents

Collaborators

• William Querbes of Boston MA (US) (3 collaborations)
• Gregory Hinkle of Plymouth MA (US) (3 collaborations)
• Abigail Liebow of Somerville MA (US) (3 collaborations)
• Brian Bettencourt of Groton MA (US) (2 collaborations)
• Muthiah Manoharan of Weston MA (US) (2 collaborations)
• Martin A. Maier of Belmont MA (US) (2 collaborations)
• Stuart Milstein of Arlington MA (US) (2 collaborations)
• Robert J. Desnick of New York NY (US) (1 collaborations)
• Makiko Yasuda of New York NY (US) (1 collaborations)
• Huilei Xu of Boston MA (US) (1 collaborations)
• David V. Erbe of Arlington MA (US) (1 collaborations)
• Mark K. Schlegel of Boston MA (US) (1 collaborations)
• Maja Janas of Cambridge MA (US) (1 collaborations)
• Vasant R. Jadhav of Sharon MA (US) (1 collaborations)
• Donald Foster of Attleboro MA (US) (1 collaborations)
• Kallanthottathil G. Rajeev of Wayland MA (US) (1 collaborations)
• Alexander V. Kel'in of Swampscott MA (US) (1 collaborations)
• Klaus Charisse of Acton MA (US) (1 collaborations)
• Jayaprakash K. Nair of Cambridge MA (US) (1 collaborations)
• Shigeo Matsuda of Cambridge MA (US) (1 collaborations)
• Muthusamy Jayaraman of Cambridge MA (US) (1 collaborations)
• Alfica Sehgal of Medford MA (US) (1 collaborations)
• Christopher Brown of Cambridge MA (US) (1 collaborations)
• David Erbe of Arlington MA (US) (1 collaborations)
• Kyle David Wood of Homewood AL (US) (1 collaborations)
• Ross Philip Holmes of Birmingham AL (US) (1 collaborations)
• John Knight of Homewood AL (US) (1 collaborations)
• James Butler of Lynnfield MA (US) (1 collaborations)
• Stephanie Williams of Littleton MA (US) (1 collaborations)
• Satyanarayana Kuchimanchi of Acton MA (US) (1 collaborations)